Lineage Cell Therapeutics, Inc. (LCTX) News
Follow Lineage Cell Therapeutics, Inc. (LCTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Lineage Cell Therapeutics gets USPTO patent issuance for AlloSCOPE™ platform
Lineage Cell Therapeutics said the USPTO has issued a patent underlying its AlloSCOPE™ 5D manufacturing platform.
EQUITY | Sep 08, 2026, 12:01 PM UTC
H
Transcript: Lineage Cell Therapeutics Q1 2026 Earnings Conference Call
On Tuesday, Lineage Cell Therapeutics (AMEX: LCTX ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. APIs provide real-time access to earnings call transcripts an
EARNINGS | Jul 01, 2026, 08:05 AM UTC